Giving magic mushrooms a try
From the Financial Times of London comes the news that a groundbreaking clinical trial funded by the British government to treat people with depression using a psychedelic extract of “magic mushrooms” is gearing up to start next year. Past research has suggested that a single exposure to psilocybin could improve psychological health for a year and decrease other symptoms of depression for six months, suggesting it has considerable therapeutic potential for the half of patients for whom antidepressants and cognitive behavioural therapy have little effect.